Table 3.

In-hospital, 1-month, 6-month, 1-year, and 2-year follow-up results.

In-hospital complications and mortality
Coronary occlusion	Nil
Annular rupture	1/25 (4%)
Minor vascular complications	4/25 (16%)
Femoral occlusion	4/25 (16%)
Femoral artery stenting	2/25 (8%)
Femoral balloon dilatation	1/25 (4%)
Groin hematoma	1/25 (4%)
Complication requiring surgical intervention	2/25 (8%)
Conduction abnormality	4/25 (16%)
Pacemaker implantation	4/25 (16%)
Acute kidney injury (recovered)	2/25
Acute kidney injury requiring dialysis	Nil
Stroke or transient ischemic attack	Nil
Atrial fibrillation	3/25 (12%)
Mortality	1/25 (4%)
Median length of stay (LoS)	6 days
Prolonged hospital stay more than 10 days	2/25 (8%)
30-day MACCE	Nil (n = 24)
6-month MACCE	Nil (n = 19)
1-year MACCE	Nil (n = 12)
2-year MACCE	Nil (n = 3)
All-cause 1-year mortality (including cardiac and noncardiac causes)	2/25 (8%)

MACCEs, major adverse cardiac and cerebrovascular events.